Literature DB >> 21510126

Patients' perspectives on end-of-life issues and implantable cardioverter defibrillators.

Patricia H Strachan1, Sandra L Carroll, Sonya de Laat, Lisa Schwartz, Heather M Arthur.   

Abstract

Increasing numbers of cardiovascular patients are receiving implantable cardioverter defibrillators (ICDs) for primary prevention of sudden cardiac death (SCD). This report examines patients' perspectives on related end-of-life issues. Using a grounded theory approach, audiotaped, semi-structured interviews were undertaken with 30 participants from two ICD referral centres in southwestern Ontario (24 who accepted an ICD and 6 who declined). Interview transcripts, verification with interviewees, researcher memos, published literature, and participant demographics were analyzed using NVivo7. Most participants were male, had comorbidities and an ejection fraction of less than 30 percent, and ranged in age from 26 to 87. Consensus was reached by three research team members on three main themes: quality versus quantity of life, preferred mode of death, and the technical realities of the ICD. The ICD was considered in relation to both quantity and quality of life. Most participants focused on the prevention of SCD, not the implications of the ICD for death by any other cause. Participants advocated for incorporating the ICD into advance care planning. Our findings have implications for the development of advance care plans and education of health professionals.

Entities:  

Mesh:

Year:  2011        PMID: 21510126      PMCID: PMC3166954     

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  22 in total

1.  Psychosocial issues of patients with implantable cardioverter defibrillators.

Authors:  Sandra B Dunbar
Journal:  Am J Crit Care       Date:  2005-07       Impact factor: 2.228

Review 2.  Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure.

Authors:  Lynne Warner Stevenson; Akshay S Desai
Journal:  J Card Fail       Date:  2006-08       Impact factor: 5.712

3.  ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.

Authors:  Andrew E Epstein; John P Dimarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney
Journal:  Heart Rhythm       Date:  2008-05-21       Impact factor: 6.343

Review 4.  Effective management of ICD patient psychosocial issues and patient critical events.

Authors:  Samuel F Sears; Melissa Matchett; Jamie B Conti
Journal:  J Cardiovasc Electrophysiol       Date:  2009-06-26

Review 5.  Rigor or rigor mortis: the problem of rigor in qualitative research revisited.

Authors:  M Sandelowski
Journal:  ANS Adv Nurs Sci       Date:  1993-12       Impact factor: 1.824

6.  Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.

Authors:  Kumaraswamy Nanthakumar; Andrew E Epstein; G Neal Kay; Vance J Plumb; Douglas S Lee
Journal:  J Am Coll Cardiol       Date:  2004-12-07       Impact factor: 24.094

7.  Brief communication: Management of implantable cardioverter-defibrillators in hospice: A nationwide survey.

Authors:  Nathan Goldstein; Melissa Carlson; Elayne Livote; Jean S Kutner
Journal:  Ann Intern Med       Date:  2010-03-02       Impact factor: 25.391

8.  Effect of cardiac and noncardiac conditions on survival after defibrillator implantation.

Authors:  Douglas S Lee; Jack V Tu; Peter C Austin; Paul Dorian; Raymond Yee; Alice Chong; David A Alter; Andreas Laupacis
Journal:  J Am Coll Cardiol       Date:  2007-06-11       Impact factor: 24.094

Review 9.  Withdrawal of cardiac medications and devices.

Authors:  Debra Lynn-McHale Wiegand; Peggy G Kalowes
Journal:  AACN Adv Crit Care       Date:  2007 Oct-Dec

Review 10.  An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life.

Authors:  J Michael Bostwick; Christopher L Sola
Journal:  Psychiatr Clin North Am       Date:  2007-12
View more
  11 in total

Review 1.  Effective communication and ethical consent in decisions related to ICDs.

Authors:  Alexander M Clark; Tiny Jaarsma; Patricia Strachan; Patricia M Davidson; Megan Jerke; James M Beattie; Amanda S Duncan; Chantal F Ski; David R Thompson
Journal:  Nat Rev Cardiol       Date:  2011-07-26       Impact factor: 32.419

2.  Readability and content of patient education material related to implantable cardioverter defibrillators.

Authors:  Patricia H Strachan; Sonya de Laat; Sandra L Carroll; Lisa Schwartz; Katie Vaandering; Gurjit K Toor; Heather M Arthur
Journal:  J Cardiovasc Nurs       Date:  2012 Nov-Dec       Impact factor: 2.083

3.  "It's not broke, so let's not try to fix it": why patients decline a cardiovascular implantable electronic device.

Authors:  Abigale L Ottenberg; Paul S Mueller; Rachel J Topazian; Sharon Kaufman; Keith M Swetz
Journal:  Pacing Clin Electrophysiol       Date:  2014-06-01       Impact factor: 1.976

4.  Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.

Authors:  Samantha M McEvedy; Jan Cameron; Eugene Lugg; Jennifer Miller; Chris Haedtke; Muna Hammash; Martha J Biddle; Kyoung Suk Lee; Justin A Mariani; Chantal F Ski; David R Thompson; Misook Lee Chung; Debra K Moser
Journal:  Palliat Med       Date:  2017-07-05       Impact factor: 4.762

Review 5.  Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives.

Authors:  Krystina B Lewis; Dawn Stacey; Dan D Matlock
Journal:  Patient       Date:  2014       Impact factor: 3.883

6.  Perceived Benefits of Implantable Cardioverter Defibrillator Implantation among Heart Failure Patients and Its Relation to Quality of Life: A Cross-Sectional Study.

Authors:  Kevser Gülcihan Balci; Mustafa Mücahit Balci; Mehmet Kadri Akboğa; Fatih Sen; Burak Açar; Samet Yılmaz; Emek Ediboğlu; Orhan Maden; Hatice Selcuk; Mehmet Timur Selcuk; Ahmet Temizhan; Sinan Aydoğdu
Journal:  Cardiol Ther       Date:  2015-09-14

7.  Health-related preferences of older patients with multimorbidity: an evidence map.

Authors:  Ana Isabel Gonzalez; Christine Schmucker; Joerg J Meerpohl; Christiane Muth; Julia Nothacker; Edith Motschall; Truc Sophia Nguyen; Maria-Sophie Brueckle; Jeanet Blom; Marjan van den Akker; Kristian Röttger; Odette Wegwarth; Tammy Hoffmann; Sharon E Straus; Ferdinand M Gerlach
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

8.  Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study.

Authors:  Jane MacIver; Alana Tibbles; Filio Billia; Heather Ross
Journal:  SAGE Open Med       Date:  2016-04-07

9.  Evaluating the feasibility of conducting a trial using a patient decision aid in implantable cardioverter defibrillator candidates: a randomized controlled feasibility trial.

Authors:  Sandra L Carroll; Dawn Stacey; Michael McGillion; Jeff S Healey; Gary Foster; Sarah Hutchings; Heather M Arthur; Gina Browne; Lehana Thabane
Journal:  Pilot Feasibility Stud       Date:  2017-11-21

10.  Are ICD recipients able to foresee if they want to withdraw therapy or deactivate defibrillator shocks?

Authors:  Ingela Thylén; Debra K Moser; Misook L Chung; Jennifer Miller; Christina Fluur; Anna Strömberg
Journal:  Int J Cardiol Heart Vessel       Date:  2013-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.